1 s2.0 S0140673616318037 Main
1 s2.0 S0140673616318037 Main
1 s2.0 S0140673616318037 Main
Summary
Background Two commonly performed surgical interventions are available for severe (grade II–IV) haemorrhoids; Lancet 2016; 388: 2375–85
traditional excisional surgery and stapled haemorrhoidopexy. Uncertainty exists as to which is most effective. The Published Online
eTHoS trial was designed to establish the clinical effectiveness and cost-effectiveness of stapled haemorrhoidopexy October 7, 2016
http://dx.doi.org/10.1016/
compared with traditional excisional surgery.
S0140-6736(16)31803-7
This online publication has been
Methods The eTHoS trial was a large, open-label, multicentre, parallel-group, pragmatic randomised controlled trial corrected. The corrected version
done in adult participants (aged 18 years or older) referred to hospital for surgical treatment for grade II–IV first appeared at thelancet.com
haemorrhoids. Participants were randomly assigned (1:1) to receive either traditional excisional surgery or stapled on October 26, 2016
haemorrhoidopexy. Randomisation was minimised according to baseline EuroQol 5 dimensions 3 level See Comment page 2328
score (EQ-5D-3L), haemorrhoid grade, sex, and centre with an automated system to stapled haemorrhoidopexy or *Members listed at end of paper
traditional excisional surgery. The primary outcome was area under the quality of life curve (AUC) measured with the Raigmore Hospital, Inverness,
EQ-5D-3L descriptive system over 24 months, assessed according to the randomised groups. The primary outcome Scotland, UK
(Prof A J M Watson FRCS); Centre
measure was analysed using linear regression with adjustment for the minimisation variables. This trial is registered
for Healthcare Randomised
with the ISRCTN registry, number ISRCTN80061723. Trials (J Hudson MSc,
J Wood BSc, A McDonald MSc,
Findings Between Jan 13, 2011, and Aug 1, 2014, 777 patients were randomised (389 to receive stapled haemorrhoidopexy Prof J Norrie MSc) and Health
Economics Research Unit
and 388 to receive traditional excisional surgery). Stapled haemorrhoidopexy was less painful than traditional
(M Kilonzo MSc, H Bruhn PhD),
excisional surgery in the short term and surgical complication rates were similar between groups. The University of Aberdeen,
EQ-5D-3L AUC score was higher in the traditional excisional surgery group than the stapled haemorrhoidopexy Aberdeen, UK; Sheffield
group over 24 months; mean difference –0·073 (95% CI –0·140 to –0·006; p=0·0342). EQ-5D-3L was higher for Teaching Hospitals, Sheffield,
UK (S R Brown MD); and Centre
stapled haemorrhoidopexy in the first 6 weeks after surgery, the traditional excisional surgery group had significantly for Statistics in Medicine,
better quality of life scores than the stapled haemorrhoidopexy group. 24 (7%) of 338 participants who received University of Oxford, Oxford,
stapled haemorrhoidopexy and 33 (9%) of 352 participants who received traditional excisional surgery had serious UK (J A Cook PhD)
adverse events. Correspondence to:
Prof Angus J M Watson,
Department of Surgery,
Interpretation As part of a tailored management plan for haemorrhoids, traditional excisional surgery should be
Raigmore Hospital,
considered over stapled haemorrhoidopexy as the surgical treatment of choice. Inverness IV2 3UJ, Scotland, UK
angus.watson@nhs.net
Funding National Institute for Health Research Health Technology Assessment programme.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
Research in context
Evidence before this study –0·140 to –0·006]; p=0·0342). Participants in the traditional
A Health Technology Assessment evidence synthesis and excisional surgery group had fewer symptoms at 12 and
six systematic reviews published between 2006 and 2015 have 24 months (both p<0·0001) and reported fewer recurrences at
assessed the role of stapled haemorrhoidopexy versus traditional 12 (39/278) and 24 months (76/300) compared with the
excisional surgery. Over 50 randomised controlled trials have stapled haemorrhoidopexy group (94/295 at 12 months and
been conducted of variable size and quality. These studies have 134/317 at 24 months). Rates of continence and tenesmus
suggested short-term pain was higher with traditional excisional were better in the traditional excisional surgery group than in
surgery than stapled haemorrhoidopexy though recurrence was the stapled haemorrhoidopexy group; complications were
also higher with stapled haemorrhoidopexy. Previous economic similar in both groups. Pain and analgesic use were lower in the
assessments of these operations were based on limited quality stapled haemorrhoidopexy group in the first 3 weeks after
of life data, and suggested a shorter operation time for stapled surgery, but time to return to normal activity 6 weeks after
haemorrhoidopexy than traditional excisional surgery. There was surgery was similar between groups. No difference was
also a paucity of medium-to-long-term clinical and economic observed in length of stay or operating time between
data regarding stapled haemorrhoidopexy or traditional groups. Traditional excisional surgery was found to be more
excisional surgery particularly for grade II haemorrhoids. cost-effective than stapled haemorrhoidopexy terms of
cost-effectiveness.
Added value of this study
We did a large multicentre, open-label, randomised controlled Implications of all the available evidence
trial of 777 patients comparing stapled haemorrhoidopexy The results of this study show that although both stapled
with traditional excisional surgery. To our knowledge, this is haemorrhoidopexy and traditional excisional surgery are
the largest trial of this treatment comparison for equally safe, traditional excisional surgery has better quality of
haemorrhoids. The overall quality of life was significantly life and is associated with fewer symptoms and recurrence of
better for the traditional excisional group than the stapled haemorrhoids. Additionally, stapled haemorrhoidopexy is more
haemorrhoidopexy group over 24 months (–0·073 [95% CI expensive and is not cost-effective.
the anatomy of haemorrhoids has improved, leading to and more advanced disease eligible for eTHoS. The
the introduction of new surgical technologies into authors of HubBLe concluded that if rubber band
clinical practice, often without previous robust ligature was considered as a course of treatment,
assessment. These technologies included stapled recurrence rates of haemorrhoids were similar to that
haemorrhoidopexy and haemorrhoidal artery ligation, with haemorrhoidal artery ligation, and haemorrhoidal
variants of which are promoted through surgical artery ligation was more expensive and not
technology industries. The purported advantages of the cost-effective.14 The aim of the eTHoS trial was to assess
new treatments, when compared with an existing whether stapled haemorrhoidopexy was more effective
surgical technique, traditional excisional surgery (or and cost-effective compared with traditional excisional
haemorrhoidectomy), were less postoperative pain with surgery in the treatment of grade II, III, and IV
similar symptom control.5 haemorrhoids. The primary objective was to compare
Despite numerous small-scale randomised controlled health-related quality of life derived over 24 months.
trials, significant doubts remain about the usefulness,
efficiency, and cost-effectiveness of stapled haem- Methods
orrhoidopexy and haemorrhoidal artery ligation.6 Study design and participants
Evidence synthesised in systematic reviews and Health The eTHoS trial was a large, open-label, multicentre,
Technology Assessments7–13 has highlighted the lack of parallel-group, pragmatic randomised controlled trial
good quality data on which to base management done in 32 UK NHS hospitals. Potential participants were
choices. This led to the National Institute of Health adults aged 18 years or older referred to hospital for
Research commissioning two trials to perform robust surgical treatment for haemorrhoids. Patients with
assessments of the newer techniques (eTHoS and haemorrhoids (grade II–IV), who provided written
haemorrhoidal artery ligation vs rubber band ligature informed consent, were eligible to take part. Participants
for the management of symptomatic grade II and III referred to hospital with haemorrhoids were included in
haemorrhoids [HubBLe]). The HubBLe trial recently the trial if their symptoms were refractory to rubber band
reported its results which compared haemorrhoidal ligature or haemorrhoidal artery ligation or if their
artery ligation with rubber band ligature. Although a haemorrhoids were thought to be too large for these
small overlap exists between HubBLe and eTHoS, the treatments to be successful. Those precluded from the
trials were designed to dovetail together with less trial included patients who had previous surgery for
advanced disease falling mainly into the HubBLe trial haemorrhoids (traditional or stapled) and those who had
previous surgical treatment for anal sphincter injury maintaining the haemorrhoids in their new position.
repair, or had symptomatic incontinence or peri-anal Stapled haemorrhoidopexy is done with the use of a
sepsis. Those with known inflammatory bowel disease or stapling gun. Three haemorrhoid stapling devices are
malignant gastrointestinal disease, within the past 5 years, commonly in use within the UK (Johnson & Johnson,
or who were deemed medically unfit for surgery, were also Chex, and Covidien). Reflecting the pragmatic nature of
ineligible, as were pregnant women. The exclusion criteria the trial, surgeons were able to use the gun which they
were set to have a minimum effect on the overall numbers normally use in their routine practice.
of participants recruited to the trial and hence maximise There are two commonly used traditional excisional
generalisability. The study was approved by the North of procedures done across the world: open19 and closed.20
Scotland Research Ethics Committee on June 18, 2010 Both have the intention of excising the haemorrhoidal
(reference number 10/20802/17). The protocol was cushions. The procedure is most commonly done with
published in 2014.15 electrocautery. In this trial, surgeons undertook whichever
procedure they would do as part of their routine practice.
Randomisation and masking The use of the Ligasure Medtronic (Minneapolis, MN,
Participants were randomly assigned (1:1) to receive USA) and Harmonic Ethicon Johnson and Johnson (NJ,
either traditional excisional surgery or stapled USA) devices to perform an excisional haemorrhoidectomy
haemorrhoidopexy with the use of an automated system were excluded in this trial. On the day of surgery, the grade
with telephone and web-based interfaces run from the of surgeon and anaesthetist and the type of anaesthesia
trial office. The randomisation minimisation algorithm and the surgical technique were recorded. Additionally, the
used included centre, grade of haemorrhoidal disease length of time the procedure took and any intraoperative
(II, III, or IV), baseline EuroQol 5 dimensions 3 level complications were recorded. Data for postoperative
(EQ-5D-3L) descriptive system score,16 and sex. Patients complications before discharge, which included post-
and investigators were not masked to treatment operative bleeding, pelvic sepsis, the need for blood
allocation. transfusion, and urinary retention were collected.
Participants were followed up for 24 months; this
Procedures consisted of a single clinic visit followed by multiple
Participants were recruited by surgeons and research postal questionnaires completed by the participant.
nurses in the outpatient department. The surgeons and Routine data were also used to measure recurrence and
research nurses were also responsible for initiating further treatment. At the 6 week clinic appointment, data
randomisation. Eligible and consented participants were for postoperative complications including haemorrhage,
placed on the appropriate waiting list by the treating requirement for blood transfusion, anal stenosis,
colorectal surgeon or a designated team member. anal fissure, urinary retention (which required
The EQ-5D-3L UK wording and population norms catheterisation), residual anal skin tags, difficult
(range –0·59 to 1·0, with 1·0 being optimum),16 36-item defecation, wound discharge, pelvic sepsis, and pruritus
Short Form Health Survey (SF-36) version 2 score, were collected. Clinical examination of the anal canal was
Cleveland incontinence score (CIS; range 0–20, with not routinely performed. Further haemorrhoid-related
0 being optimum), and Haemorrhoid symptom score interventions since discharge and the need for further
(HSS; 0–26 range, with 0 being optimum) were collected planned medical and/or surgical treatments for
pre-randomisation as baseline measures.17,18 Other data haemorrhoids or complications associated with treat-
collected at baseline included height, weight, grade of ment were recorded. Postoperative examination of the
haemorrhoid, anticoagulant medication prescriptions, anal canal during the 6 week follow-up clinic was
and previous treatments for haemorrhoids. Each centre’s included in the protocol but was not done routinely if
participating surgeons had received appropriate patients reported that their symptoms were improving.
recognised training for both stapled and traditional This is in line with current practice and was also adhered
haemorrhoid surgery and were using the procedures to in the HubBLe trial.
routinely in their hospitals. Surgery was only done by EQ-5D-3L and visual analogue scale (VAS) pain data
surgeons in the late stage of training if they had been were collected by postal questionnaire at 1 and 3 weeks
signed off by their supervising consultant surgeon, or if after surgery. EQ-5D-3L, SF-36, HSS, CIS, and VAS data
they were operating under the direct supervision of their were collected by postal questionnaire at 6 weeks
consultant. Preoperative and postoperative care followed after surgery. Additionally, questionnaires distributed at
the respective surgeon’s and NHS hospital’s standard 12 and 24 months after randomisation also collected data
policies. Stapled haemorrhoidopexy aims to correct for patient-reported haemorrhoid recurrence and further
haemorrhoidal prolapse by excising a ring of tissue above operations. Participants who did not respond to 12 and
the haemorrhoidal cushions with immediate re- 24 month questionnaires were sent a postal reminder
anastomosis of the mucosa with the use of staples. and a shortened version of the questionnaire containing
A secondary effect might be to reduce blood flow and the EQ-5D-3L only. The main outcome assessment was
therefore congestion. Fibrosis develops at the staple line planned at 24 months (from the date of randomisation)
Outcomes
The primary outcome was the area under the quality of
389 assigned to stapled 388 assigned to traditional life curve (AUC) over 24 months derived from
haemorrhoidopexy excisional surgery
EQ-5D-3L measurements taken from patient question-
naires distributed at baseline, 1 week, 3 weeks, 6 weeks
1 post-randomisation 2 post-randomisation (postoperative), 12 months, and 24 months post-
exclusion exclusions
randomisation. The AUC is expressed in years and can be
interpreted as quality-adjusted life-years (QALYs). The
388 had clinical assessment 386 had clinical assessment primary trial economic outcome was incremental costs per
at baseline at baseline QALY gained with QALYs based on the responses to the
388 responded to questionnaire 386 responded to questionnaire
at baseline EQ-5D-3L over 24 months. Patient-reported secondary
outcomes were generic health profile measured by SF-36
and EQ-5D-3L, VAS pain score, CIS, HSS, postoperative
8 withdrew before surgery 7 withdrew before surgery
1 died before surgery 0 died before surgery analgesia consumption, recurrence of haemorrhoids, and
21 did not receive surgery 16 did not receive surgery tenesmus. Tenesmus can be a disabling symptom which is
described as a feeling of wanting to pass stool, even though
358 had surgery 363 had surgery
the rectum is empty. The clinical secondary outcomes were
301 had stapled 323 had traditional further interventions, intraoperative and postoperative
haemorrhoidopexy excisional surgery complications including haemorrhage, requirement for
37 had traditional 29 had stapled
excisional surgery haemorrhoidopexy blood transfusion, anal stenosis, anal fissure, urinary
18 had other surgical 11 had other surgical retention (which required catheterisation), residual anal
technique technique
2 unknown
skin tags, difficult defecation, wound discharge, pelvic
sepsis, and pruritus. A serious adverse event was defined
as an event occurring to a research participant that was
Follow-up 1 week after surgery Follow-up 1 week after surgery
301 completed questionnaire 296 completed questionnaire
treatment related (resulted from administration of any of
0 withdrew 3 withdrew the research procedures) and was expected or unexpected
that caused death, was life threatening, required hospital
admission, resulted in significant incapacity or disability,
Follow-up 3 weeks after surgery Follow-up 3 weeks after surgery
291 completed questionnaire 282 completed questionnaire or was otherwise considered medically significant by the
1 withdrew 3 withdrew investigators. Death, related or not to the study treatment,
was also recorded.
Follow-up 6 weeks after surgery Follow-up 6 weeks after surgery
347 had clinical assessment 357 had clinical assessment Statistical analysis
309 completed questionnaire 305 completed questionnaire
2 withdrew 5 withdrew
A sample size of 338 per group was required to provide
90% power to detect a difference in the mean area under
the quality of life AUC curve of 0·25 SDs derived from
Follow-up 12 months after Follow-up 12 months after EQ-5D-3L score measurements, with a significance
randomisation randomisation
295 completed questionnaire 278 completed questionnaire level of 5% (two-sided α). Data for the EQ-5D-3L AUC,
11 withdrew 14 withdrew in this patient group, were limited at the time of study
2 died 0 died
conduct but an SD of 0·25 was thought to be sufficient
to detect a worthwhile difference in quality of life
Follow-up 24 months after Follow-up 24 months after measures. To allow for 15% non-response in the
randomisation randomisation
288 completed questionnaire 274 completed questionnaire outcome, we randomly assigned 400 patients in each of
15 withdrew 16 withdrew the two groups. Such a sample size would also provide
2 died 0 died
0·9
excisional surgery group. Surgical trainees performed
58 (16%) of 358 stapled haemorrhoidopexy procedures
and 89 (25%) of 363 traditional excisional surgeries.
Specialty doctors performed the remaining operations
0·8
(32 [9%] of 358 in the stapled haemorrhoidopexy group
vs 37 [10%] of 363 in the traditional excisional surgery
group). No differences were noted between the duration
EQ-5D score
after randomisation (table 2). Participants were asked 6 weeks 48·2 (10·4); 294 48·9 (9·2); 293 –0·58 (–1·77 to 0·61) 0·34
about the presence of tenesmus at 6 weeks, 12 months, 12 months 49·7 (10·1); 265 51·2 (9·4); 255 –1·79 (–3·06 to –0·51) 0·0059
and 24 months. Tenesmus was more prevalent in the 24 months 50·3 (10·1); 250 51·1 (9·4); 234 –1·15 (–2·47 to 0·16) 0·0860
stapled haemorrhoidopexy group throughout the follow- Mental component summary
up period (table 2). Baseline 48·8 (11·7); 380 49·6 (11·0); 377 ·· ·· ··
Serious adverse events were reported by treatment 6 weeks 47·3 (12·7); 294 48·7 (11·7); 293 –0·55 (–2·07 to 0·97) 0·48
received. 24 (7%) participants had a serious adverse event
12 months 48·8 (12·2); 265 51·2 (10·4); 255 –1·71 (–3·34 to –0·08) 0·0396
after undergoing stapled haemorrhoidopexy and 33 (9%)
24 months 49·8 (11·2); 250 51·0 (10·9); 234 –0·89 (–2·57 to 0·80) 0·30
after receiving traditional excisional surgery (table 4).
One participant died in the stapled haemorrhoidopexy Tenesmus
group, but this death was unrelated to haemorrhoid 6 weeks
surgery. Most hospital admissions were for pain, Participants 309 305 ·· ·· 0·0010
bleeding, constipation, and urinary retention. Only followed up
two participants received a blood transfusion Always 17 (6%) 9 (3%) ·· ·· ··
(one participant had low concentration of haemoglobin Often 42 (14%) 20 (7%) ·· ·· ··
before surgery and one participant was readmitted 1 week Sometimes 82 (27%) 75 (25%) ·· ·· ··
after surgery with severe postoperative bleeding, Rarely 58 (19%) 68 (22%) ·· ·· ··
requiring an extensive hospital stay). 11 participants Never 109 (35%) 131 (43%) ·· ·· ··
required catheterisation for urinary retention; seven had
Missing 1 (<1%) 2 (1%) ·· ·· ··
received traditional excisional surgery and four stapled
12 months
haemorrhoidopexy. Ten participants remained in hospital
Participants 295 278 ·· ·· <0·0001
or were readmitted with pain in the traditional excisional
followed up
surgery group compared with six in the stapled
Always 11 (4%) 4 (1%) ·· ·· ··
haemorrhoidopexy group. A few participants had a
Often 27 (9%) 7 (3%) ·· ·· ··
combination of pain, constipation, and bleeding, but
bleeding on its own was more common in the stapled Sometimes 60 (20%) 46 (17%) ·· ·· ··
haemorrhoidopexy group than in the traditional Rarely 65 (22%) 43 (15%) ·· ·· ··
excisional surgery group. Two participants in each group Never 113 (38%) 154 (55%) ·· ·· ··
reported pain caused by an anal fissure. No episodes of Missing 19 (6%) 24 (9%) ·· ·· ··
pelvic sepsis or rectal perforation were recorded in 24 months
this trial. (Table 2 continues on next page)
The mean cost per patient for stapled haemorrhoidopexy
was £941 (SD 415) compared with £602 (507) for traditional
excisional surgery (appendix p 3). The adjusted analysis adjusted analysis mean difference in QALYs between
mean difference in total costs was £337 (95% CI 251–423) groups was –0·070 (95% CI –0·127 to –0·011). Overall,
higher for stapled haemorrhoidopexy than for traditional stapled haemorrhoidopexy cost more than traditional
excisional surgery. The QALY results for the stapled excisional surgery and had a lower number of QALYs than
haemorrhoidopexy group were 1·62 (SD 0·43) and 1·69 traditional excisional surgery. The cost utility analysis
(0·38) for the traditional excisional surgery group. The indicated that stapled haemorrhoidopexy has <0·1%
haemorrhoidopexy was equivalent to that in the colleagues.7 In their study, Burch and colleagues reported
traditional excisional surgery group 6 weeks post- that traditional excisional surgery and stapled
operatively. haemorrhoidopexy had similar costs and QALYs, but
Clinical recurrence of haemorrhoids was measured that the costs of the staple gun were offset by savings in
using HSS, a patient-reported dichotomous outcome hospital stay. In our study, the inpatient stay was similar
measure, and recurrence data from national databases across both groups, so no cost saving in inpatient stay
(ISD, HES, PEDW). Although the HSS has not been was reported, and our QALY results, on the basis of a
formally validated, the rationale for its use has been 24 month follow-up, indicated that stapled haemorrhoid-
previously articulated14 and at the inception of the trial it opexy had lower QALYs than traditional excisional
was the best assessment tool available. We chose to surgery. A paucity of robust economic data is available
assess recurrence over 24 months expecting to capture a on haemorrhoid surgery, however, if the results of these
proportion of patients who report symptom relapse contemporaneous trials are put into practice, substantial
after 12 months, and we found this to be the case. Little annual savings in publicly funded health services could
data are available concerning the long-term success be achieved.
rates of haemorrhoid surgery and after 24 months, Several decisions were made reflecting the pragmatic
distinguishing between symptoms caused by inadequate nature of the study’s conception and design and the aim to
initial treatment and the occurrence of new disease reflect routine care. First, the study was open label in that
would be important.10 no attempt was made to mask participants (who were
Continence was an important outcome measure for this generally the outcome assessor) or the surgeon to treatment
trial. The anal sphincter complex is comprised of two allocation. The presence or absence of peri-anal wounds
concentric muscles. Anal cushions (which form the basis would render masking impossible in the short term. No
of haemorrhoids) in the upper part of the canal contribute prescriptive entry criteria were set for hospital inclusion
to continence by acting as washers helping to form a seal. and we are therefore confident that the results are
Prolapsing haemorrhoids, therefore, interfere with this generalisable across health services. A 24 month follow-up
mechanism by disrupting the sealing mechanism of the was used to capture symptom recurrence and further
sphincters and cushions working in concert. The interventions; therefore, a median follow-up of 731 days
traditional excisional surgery technique involves removing was a further strength of this study. A pragmatic approach
tissue close to the internal sphincter. Damage and therefore to surgeons’ credentials was used. At the inception of the
impairment of continence is widely reported after trial, both techniques were established in common surgical
traditional excisional surgery.26 The optimum technique practice and surgeons must have undergone appropriate
for stapled haemorrhoidopexy involves the accurate recognised training for both procedures. Ideally, this will
placement of the staple line 3–4 cm from the anal verge have included attendance at a masterclass. The effect of
and therefore above the dentate line in the columnar surgical experience on outcomes can be partly mitigated by
mucosa of the anal canal. Staple lines lower than this the high level of consultant involvement in performing the
might encroach on the more sensate squamous mucosa of surgery and the low incidence of adverse events.
the anal canal contributing to an increase in postoperative The trial had several limitations. As noted previously,
pain and a greater chance of injuring the internal participants and outcome assessors were not masked to
sphincter.27 As expected, in the immediate postoperative treatment assignment which could have led to bias when
period, CIS was impaired in both groups at 6 weeks when measuring the subjective outcomes. Final recruitment
compared with baseline scores, explained by the presence to eTHoS was slightly short of the total target of
of pain and healing. Thereafter, continence scores were 800 participants and, furthermore, there were
significantly improved in the traditional excisional surgery substantial, and greater than anticipated, missing data at
group up to 24 months after randomisation. High quality 24 months follow-up despite multiple strategies to
surgery and the avoidance of sphincter injury in both mitigate this. This, perhaps, reflected the population
groups, and a reduction in the volume of haemorrhoid (working age), the condition (chronic and considered by
tissue, could explain the slight improvement in continence some to be a sensitive subject), and the nature of the
scores over the course of the trial. follow-up. Nevertheless, the study still had sufficient
The economic analysis showed that traditional statistical precision to detect differences between
excisional surgery cost £337 less and had 0·07 more treatment groups. Various secondary analyses explored
QALYs than the stapled haemorrhoidopexy group over plausible imputation and missing data assumptions
the 24 month follow-up period. Stapled haemorrhoid- regarding quality of life and a consistent pattern of
opexy has a 0·1% probability of being considered cost- benefit in favour of traditional excisional surgery was
effective at the £30 000 threshold. Taken together with reported. A noticeable amount of non-compliance with
the HubBLe health-care cost analysis, both trials report allocation (some not receiving surgery, and some
that neither of the newer surgical techniques are receiving a different operation) was noted reflecting
cost-effective. The results of the economic analysis differ perhaps a mixture of clinical reality and also some
from those published in the study by Burch and surgeon and patient preferences regarding treatment.
Such non-compliance tends to dilute a genuine effect. high quality randomised controlled trials incorporating
We assessed the effect of non-compliance in the per- economic cost comparisons, and an updated network
protocol population (appendix p 1). Despite this, the meta-analysis incorporating these two large trials would
primary analysis still supported a difference in favour of be appropriate.
traditional excisional surgery, and the per-protocol Overall, traditional excisional surgery is both more
analysis of only those who complied with allocation was clinically effective and less costly when compared with
consistent with this finding. The delivery of the stapled haemorrhoidopexy. It is more painful in the
interventions reflected routine clinical practice across a short term but this pain can be adequately managed at
range of centres in terms of the surgeons participating home. Time to return to normal activity was similar in
(their experience) and how the interventions were both groups. In addition to superior quality of life
delivered (specific technique, centre practices). Com- measures, HSS, continence, and tenesmus rates and
parison of outcome between surgeons and surgical the need for further surgery were all lower with
practice was difficult in this context because of the traditional excisional surgery. Traditional excisional
numerous factors which affect patients and centres surgery is, therefore, a superior surgical treatment to
which were not attributable to the surgeon. Taken stapled haemorrhoidopexy for the management of
together, we believe the findings are robust and grade II–IV haemorrhoids.
generalisable. Contributors
The interventions compared in eTHoS reflected clinical AJMW (Chief Investigator), SRB (Chief Investigator HubBLe), JW
practice in the UK NHS at the time of its design. During (Trial Manager), JH (Statistician), MK (Health Economist), and JAC
(Senior Trialist) produced the first draft of the manuscript. AJMW,
the recruitment period a new intervention, haemorrhoidal JN (Director of CHaRT), JAC, AM, MK conceived of or designed the
artery ligation, started being used. The HubBLe trial work. The eTHoS study team including HB (Trial Manager) contributed
showed no benefit for haemorrhoidal artery ligation over to the acquisition of data for the work. JH, MK and JAC analysed the
rubber band ligation.14 Together with eTHoS, these studies data. AJMW, SRB, JAC, JH, MK, AM, JN, and JW contributed to the
interpretation of findings and the reporting of the study.
suggest a pattern of failure of new and purported better
interventions to achieve sufficient clinical outcome at an eTHoS study group
AJM Watson (lead clinician; NHS Highland, Inverness); M Loudon,
appropriate cost. They provide a warning about the C Parnaby (who replaced M Loudon on Dec 30, 2014), A Grant (NHS
widespread adoption of expensive and unproven new Grampian, Aberdeen); A Agarwal (North Tees and Hartlepool NHS
procedures. The IDEAL framework28–30 provides a potential Foundation, Hartlepool); S Brown (Sheffield Teaching Hospitals NHS
pathway from idea to robust assessment, though to date, Foundation Trust, Sheffield), J Varma, V Shanmugan (who replaced
J Varma on March 1, 2012; County Durham and Darlington NHS
while perhaps improving, surgical assesement is still often Foundation Trust, Durham); D Jayne (The Leeds Teaching Hospitals
too late and not rigorous enough. NHS Trust, Leeds), S Kapur (Norfolk and Norwich University Hospitals
The introduction of new surgical treatments for NHS Trust, Norwich); F Curran (Central Manchester University
haemorrhoids has been accompanied by the greater Hospitals NHS Foundation Trust, Manchester), P Tekkis (Chelsea and
Westminster Hospital NHS Foundation Trust, London); G Sunderland
incidence of reporting of adverse events. Some of the (NHS Greater Glasgow and Clyde, Glasgow); R Rajagopal
published postoperative complications after surgery for a (Betsi Cadwaladr University Health Board, Wales); I Lindsey (Oxford
benign condition, have been severe, particularly with University Hospitals NHS Foundation Trust, Oxford); C Barben
(Aintree University Hospital, NHS Foundation Trust, Liverpool);
regard to pelvic sepsis, rectal perforation, and rectovaginal
M Lamah (Brighton and Sussex University Hospitals NHS Trust,
fistula formation.31 There were no reports of these Brighton); M Jha (South Tees Hospitals NHS Foundation Trust,
complications within this trial, which might reflect safe Middlesbrough); S Anwar (Calderdale and Huddersfield NHS
surgical practice within trial centres or that complications Foundation Trust, Huddersfield), L Titu (Wirral University Teaching
Hospital, Wirral); A Abulafi (Croydon Health Services NHS Trust,
occur more frequently within the earlier part of surgical
Croydon), P Mathur (Royal Free London NHS Foundation Trust);
learning curves. Serious adverse events were equally H Narula, A Fawole (who replaced H Narula on April 8, 2014; The Mid
distributed in both groups. All the events were expected Yorkshire Hospitals NHS Trust, Wakefield); P Arumugam (Royal
and largely consisted of pain, bleeding, constipation, and Cornwall Hospitals NHS Trust, Cornwall), Y Mohsen (The Hillingdon
Hospitals NHS Foundation Trust, London); R Delicata (Bwrdd lechyd
urinary retention.
Aneurin Bevan NHS Trust, Wales), R West (Weston Area Health NHS
The findings in this trial can be compared with a recent Trust); R Speake (Derby Hospitals NHS Foundation Trust, Derby);
network meta-analysis,10 which included 98 trials of E MacDonald (NHS Forth Valley, Stirling); M Mercer-Jones (Gateshead
procedures for grade III and IV haemorrhoids in the Health NHS Foundation Trust, Gateshead), M Tutton (Colchester
Hospital University NHS Foundation Trust, Colchester); M Zammit
analysis. The authors suggested that traditional excisional (Basildon and Thurrock University Hospitals NHS Foundation Trust,
surgery was associated with fewer haemorrhoid Basildon); S Pillai (United Lincolnshire Hospitals NHS Trust, Lincoln);
recurrences and that stapled haemorrhoidopexy was A Sharma (University Hospital of South Manchester NHS Foundation
associated with less postoperative pain and a higher rate Trust, Manchester); B Buckley (University of the Philippines, Manila).
of recurrence. However, the eTHoS trial refutes the data Declaration of interests
on higher complications rates, return to normal activity, AJMW, JH, JW, MK, SRB, AM, JN, HB, and JAC report grants from
National Institute for Health Research Health (NIHR) Technology
length of operation, and length of stay in traditional Assessment (HTA) programme during the conduct of the study. JN is a
excisional surgery. Taken together, the HubBLe and member of the NIHR HTA Efficacy and Mechanism Evaluation editorial
eTHoS trials, also answer the authors call for further board, outside the submitted work.